Large cell neuroendocrine carcinoma with sarcomatous changes of the endometrium: A case report with immunohistochemical studies and molecular genetic study of KIT and PDGFRA

Pathology Research and Practice

Volumn 206, Issue 6, 2010, Pages 420-425

  Terada, Tadashi ^a  

^a SHIZUOKA CITY SHIMIZU HOSPITAL   (Japan)

Author keywords

Endometrium; Neuroendocrine carcinoma; Sarcomatous changes

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANTINEOPLASTIC AGENT; CA 125 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CD34 ANTIGEN; CD56 ANTIGEN; CHROMOGRANIN; CYTOKERATIN; DESMIN; EPITHELIAL MEMBRANE ANTIGEN; ESTROGEN RECEPTOR; KI 67 ANTIGEN; NEURON SPECIFIC ENOLASE; PLATELET DERIVED GROWTH FACTOR A; PROGESTERONE RECEPTOR; PROTEIN P53; PROTEIN S 100; STEM CELL FACTOR RECEPTOR; SYNAPTOPHYSIN; VIMENTIN;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CURETTAGE; ECHOGRAPHY; ENDOMETRIUM CARCINOMA; EXON; FEMALE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; LARGE CELL CARCINOMA; LYMPH NODE DISSECTION; MELANOSOME; MOLECULAR GENETICS; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; OMENTECTOMY; SALPINGOOOPHORECTOMY; UTERUS BIOPSY; UTERUS BLEEDING;

ANTINEOPLASTIC AGENTS; CARCINOMA, LARGE CELL; CARCINOMA, NEUROENDOCRINE; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; ENDOMETRIAL NEOPLASMS; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; STEM CELL FACTOR; TUMOR MARKERS, BIOLOGICAL;

EID: 77953230910     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2009.12.008     Document Type: Article

References (30)

1. Travis W., Nicholson S., Hirsch F.R., et al. Small cell carcinoma. WHO Classification of Tumour. Pathology and Genetics of Tumours of the Lung Pleura, Thymus and Heart 2004, 31-34. IARC Press, Lyon. W.D. Travis, E. Blambillia, K. Muller-Hermelink, C.C. Harris (Eds.).
2. Brambilla E., Pugatch B., Geisinger K., et al. Large cell carcinoma. WHO Classification of Tumour. Pathology and Genetics of Tumours of the Lung Pleura, Thymus and Heart 2004, 45-50. IARC press, Lyon. W.D. Travis, E. Blambillia, K. Muller-Hermelink, C.C. Harris (Eds.).
3. Mulvany N.J., Allen D.G. Combined large cell neuroendocrine and endometrial carcinoma of the endometrium. Int. J. Gynecol. Pathol. 2008, 27:49-57.
4. Albores-Saavedra J., Martinez-Benitez B., Luevano E. Small cell carcinomas and large cell neuroendocrine carcinomas of the endometrium and cervix: polypoid tumors and those arising in polyps may have a favorable prognosis. Int. J. Gynecol. Pathol. 2008, 27:333-339.
5. Huntsman D.G., Clement P.B., Gilks C.B., Scully R.E. Small-cell carcinoma of the endometrium: a clinicopathological study of sixteen cases. Am. J. Surg. Pathol. 1994, 18:364-375.
6. Li W.W., Yau T.N., Leung C.W., Pong W.M., Chan M.Y. Large-cell neuroendocrine carcinoma of the uterine cervix. Hong Kong Med. J. 2009, 15:69-72.
7. Ko M.L., Jeng C.J., Huang S.H., Shen J., Chen S.C., Tzeng C.R. Large cell neuroendocrine carcinoma of the uterine cervix. Taiwan J. Obstet. Gynecol. 2007, 46:68-70.
8. Wang K.L., Yang Y.C., Wang T.Y., Chen J.R., Chen T.C., Chen H.S., Su T.H., Wang K.G. Neuroendocrine carcinoma of uterine cervix: a clinicopathologic retrospective study of 31 cases with prognostic implications. J. Chemother. 2006, 18:209-216.
9. Tsou M.H., Tan T.D., Cheng S.H., Chiou Y.K. Small cell carcinoma of uterine cervix with large cell neuroendocrine carcinoma component. Gynecol. Oncol. 1998, 68:69-72.
10. Kawauchi S., Okuda S., Morioka H., Iwasaki F., Fukuma F., Chochi Y., Furuya T., Oga A., Sasaki K. Large cell neuroendocrine carcinoma of the uterine cervix with cytogenetic analyses by comparative genomic hybridization: a case study. Hum. Pathol. 2005, 36:1096-1100.
11. Gilks C.B., Young R.H., Gersell D.J., Clement P.B. Large cell neuroendocrine carcinoma of the uterine cervix. A clinicopathologic study of 12 cases. Am. J. Surg. Pathol. 1997, 21:905-914.
12. Terada T., Kawaguchi M., Furukawa K., Sekido Y., Osamura Y. Minute mixed ductal-endocrine carcinoma of the pancreas with predominant intraductal growth. Pathol. Int. 2002, 52:740-746.
13. Terada T. Large endocervical polyp with cartilaginous and osseous metaplasia: a hitherto unreported entity. Int. J. Gynecol. Pathol. 2009, 28:98-100.
14. Terada T. Gastrointestinal stromal tumor of the uterus: a case report with genetic analyses of c-kit and PDGFRA genes. Int. J. Gynecol. Pathol. 2009, 28:29-34.
15. Terada T. Primary extragastrointestinal stromal tumors of the transverse mesocolon without c-kit mutations but with PDGFRA mutations. Med. Oncol. 2009, 26:233-237.
16. Terada T. Primary multiple extragastrointestinal stromal tumors of the omentum with different mutations of c-kit gene. Would J. Gastroenterol. 2008, 14:7256-7259.
17. Hirota S., Isozaki K. Pathology of gastrointestinal stromal tumor. Pathol. Int. 2006, 56:1-9.
18. Miettinen M., Lasota J. KIT (CD117): a review on expression in normal and neoplastic tissue, and mutations and their clinicopathologic correlation. Appl. Immunohistochem. Mol. Morphol. 2005, 13:205-220.
19. Roncaroli F., Montironi R., Fellcoiotti F., Losi L., Eusebi V. Sarcomatoid carcinoma of the anorectal junction with neuroendocrine and rhabdomyoblastic features. Am. J. Surg. Pathol. 1995, 19:217-223.
20. Boldrini L., Ursino S., Gisfredi S., Faviana P., Donati V., Camcci T., Lucchi M., Mussi A., Basolo F., Pingitore R., Fontanini G. Expression and mutational status of c-kit in small-cell lung cancer: prognostic relevance. Clin. Cancer Res. 2004, 15:4101-4108.
21. Burger H., Den Bakker M.A., Stoter G., Verweij J., Nooter K. Lack of c-kit exon 11 activating mutations in c-kit/CD117-positive SCLC tumor specimens. Eur. J. Cancer 2003, 39:793-799.
22. Sihto H., Sarlomo-Rikara M., Tynnienen O., Tanner M., Andersson L.C., Franssila K., Nupponen N.N., Joensuu H. KIT and platelet-derived growth factor receptor alpha tyrosine kinase gene mutations and KIT amplifications in human solid tumors. J. Clin. Oncol. 2005, 23:49-57.
23. Terada T primary small cell carcinoma of the mediastinum: a case report with immunohistochemical and molecular genetic analyses of KIT and PDGFRA genes. Med. Oncol. 2009, 26:247-250.
24. Terada T, Primary small cell carcinoma of the ureter: a case report with immunohistochemical and molecular genetic analysis of KIT and PDGFRA genes, Pathology, 42 (2010) 101-102.
25. Terada T. Autopsy case of primary small cell carcinoma of the urinary bladder: KIT and PDGFRA expression and mutations. Pathol. Int. 2009, 59:247-250.
26. Araki K., Ishii G., Yokose T., Nagai K., Funaki K., Kodama K., Nishiwaki Y., Ochiai A. Frequent overexpression of the c-kit protein in large cell neuroendocrine carcinoma of the lung. Lung Cancer 2003, 40:173-180.
27. Pelosi G., Masullo M., Leon M.E., Veronesi G., Spaggaiari L., et al. CD117 immunoreactivity in high grade neuroendocrine tumors of the lung. Virchows Arch. 2004, 445:449-455.
28. Casali C., Stefani A., Rossi G., Migaldi M., Bettelli S., Parise A., Morandi U. The prognostic role of c-kit protein in resected large cell neuroendocrine carcinoma of the lung. Ann. Thorac. Surg. 2004, 77:247-252.
29. Rossi G., Cavezza A., Marchioni A., Longo L., Migaldi M., et al. Role of chemotherapy and the receptor tyrosine kinases KIT, PDGFRalpha, PDGFRbeta, and Met in large cell neuroendocrine carcinoma of the lung. J. Clin. Oncol. 2005, 23:8774-8785.
30. Lapoint R.J., Bourne P.A., Wang H.L., Xu H. Coexpression of c-kit and bcl-2 in small cell carcinoma and large cell neuroendocrine carcinoma of the lung. Appl. Immunohistochem. Mol. Morphol. 2007, 15:401-406.